Skip to content
Screener

Treasury Stock at other companies

KORU Medical Systems logo
KORU Medical SystemsKRMD
$6.41M+65.0%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$1.1B+47.5%
ICU Medical logo
ICU MedicalICUI
$23.42M+390,150%
Omnicell logo
OmnicellOMCL
$368.31M+20.4%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$17.92M+10.4%
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc.IRTC
$25M0.0%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$14.24B+18.2%
Enterprise value$12.45B+17.5%
P/S1.3×+0.2×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The source filing: Baxter International’s 10-Q, filed April 30, 2026.

Filed
Apr 30, 2026, 4:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-028962
Line itemMarch 31,2026December 31,2025
Commitments and contingencies
Equity:
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2026 and 2025683683
Common stock in treasury, at cost, 167,047,900 shares in 2026 and 169,213,617 shares in 2025(10,737)(10,873)
Additional contributed capital6,2146,368
Retained earnings13,68513,705
Accumulated other comprehensive loss(3,802)(3,754)
Total Baxter stockholders’ equity6,0436,129

Item 1. Financial Statements (unaudited)

FAQ

What is Baxter International's treasury stock?
Baxter International (BAX) reported treasury stock of $10.74B in Q1 2026.
How has Baxter International's treasury stock changed year-over-year?
Baxter International's treasury stock decreased by 1.8% year-over-year, from $10.94B to $10.74B.
What is the long-term trend for Baxter International's treasury stock?
Over 5 years (2020 to 2025), Baxter International's treasury stock has grown at a -0.3% compound annual growth rate (CAGR), from $11.05B to $10.87B.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Ask your AI about Baxter International's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude